|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBOOKCENTRAL_on1001374578 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170819s2017 ts ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d MERUC
|d YDX
|d OCLCQ
|d N$T
|d G3B
|d IGB
|d STF
|d OCLCF
|d OCLCQ
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 1001260936
|
| 020 |
|
|
|a 1681084937
|
| 020 |
|
|
|a 9781681084930
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000065567927
|
| 035 |
|
|
|a (OCoLC)1001374578
|z (OCoLC)1001260936
|
| 050 |
|
4 |
|a R855.3
|
| 072 |
|
7 |
|a HEA
|x 012000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 020000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 004000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 101000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 109000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 029000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 040000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 092000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Nanomedicine and Neurosciences :
|b Advantages, limitations and safety aspects /
|c editor, Giovanni Toasi.
|
| 260 |
|
|
|a Sharjah :
|b Bentham Science Publishers,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (285 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Frontiers in Nanomedicine ;
|v v. 2
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a FOREWORD ; PREFACE ; List of Contributors ; Nanomedicine and Neurodegenerative Diseases: An Introduction to Pathology and Drug Targets ; Tasnuva Sarowar1 and Andreas M. Grabrucker2,*; INTRODUCTION; CLINICAL REPRESENTATIONS; Alzheimer's Disease; Core Features of AD; Symptoms & Diagnosis of AD; Parkinson's Disease; Symptoms & Core Features of PD; Diagnosis of PD; Amytropohic Lateral Sclerosis; Core Features of ALS; Symptoms & Diagnosis of ALS; ANATOMY AND PATHOLOGY; Initiation and Progression; Alzheimer's Disease; Parkinson's Disease; Other Neurodegenerative Disorders.
|
| 505 |
8 |
|
|a Brain Morphology, Cellular Pathology and Neurobiology of the DiseaseAlzheimer's Disease; Parkinson's Disease; Amyloid Lateral Sclerosis; GENES AND ENVIRONMENT; ; Genetics of Neurodegenerative Diseases; Candidate Genes for Alzheimer's Disease; Parkinson's Disease; Candidate Genes for Parkinson's Disease; Candidate Genes for ALS; Environmental Risk Factors; Trace Metal Alterations; Other Risk Factors; ANIMAL MODELS; Animal Models for AD; Animal Models for PD; Animal Models for ALS; Animal Models for HD; DRUG TARGETS IN NEURODEGENERATIVE DISORDERS; Drug Targets in AD; Drug Targets in PD.
|
| 505 |
8 |
|
|a TREATMENT OF NEURODEGENERATIVE DISORDERS USING NANOMEDICINECONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGEMENT; REFERENCES; Nanoparticles Targeting Mitochondria in Neurodegenerative Diseases: Toxicity and Challenge for Nanotherapeutics ; Michal Cagalinec*; INTRODUCTION AND OVERVIEW; ALZHEIMER'S AND PARKINSON'S DISEASE; MITOCHONDRIA; MITOCHONDRIAL FUSION AND FISSION; NANOPARTICLES AND THE BRAIN; NANOPARTICLES' TOXICITY, FOCUS ON NEUROTOXICITY; NANOPARTICLES AS DRUG CARRIERS; MITOCHONDRIA AND ALZHEIMER'S DISEASE; MITOCHONDRIA AND PARKINSON'S DISEASE.
|
| 505 |
8 |
|
|a NANOPARTICLES AND ALZHEIMER'S DISEASE TREATMENTNANOPARTICLES AND PARKINSON'S DISEASE TREATMENT; NANOPARTICLES AS DRUG DELIVERY SYSTEMS TO MITO- CHONDRIA; COULD NANOPARTICLES IMPROVE MITOCHONDRIAL FUNCTION- ING WITHOUT ENTERING MITOCHONDRIA?; FUTURE DIRECTIONS, PERSPECTIVES, LIMITATIONS; CONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; ABBREVIATIONS; REFERENCES; Neuronal Mechanisms for Nanotopography Sensing ; Ilaria Tonazzini1,2 and Marco Cecchini1,*; INTRODUCTION; Focal Adhesions and Cytoskeleton during Neuronal Cell-nanograting Interaction.
|
| 505 |
8 |
|
|a Neuronal Differentiation Drives Nanotopography SensingNoise Tolerance in Neuronal Contact Guidance; CONCLUSIONS; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; Drug Delivery to the Brain by Liposomal Carrier Systems ; Anne Mahringer and Gert Fricker*; INTRODUCTION; LIPOSOMES; TRANSFERRIN RECEPTOR; INSULIN RECEPTOR; LDL RECEPTOR; LEPTIN RECEPTOR; RECEPTOR OF ADVANCED GLYCATION END PRODUCTS; ABSORPTIVE-MEDIATED TRANSCYTOSIS ACROSS THE BBB; ULTRASOUND AND LIPOSOMES TO OVERCOME THE BBB; CONCLUSION; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES.
|
| 500 |
|
|
|a Neuronopathic LSDs: Quest for Treatments Drives Research in Nanomedicine and Nanotechnology.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Medical technology.
|
| 650 |
|
0 |
|a Nanotechnology.
|
| 650 |
|
0 |
|a Medical innovations.
|
| 650 |
|
2 |
|a Medical Laboratory Science
|
| 650 |
|
2 |
|a Nanotechnology
|
| 650 |
|
6 |
|a Technologie médicale.
|
| 650 |
|
6 |
|a Médecine
|x Innovations.
|
| 650 |
|
6 |
|a Nanotechnologie.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Holism.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Reference.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Alternative Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Atlases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Essays.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Family & General Practice.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Holistic Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Osteopathy.
|2 bisacsh
|
| 650 |
|
7 |
|a Medical innovations
|2 fast
|
| 650 |
|
7 |
|a Medical technology
|2 fast
|
| 650 |
|
7 |
|a Nanotechnology
|2 fast
|
| 700 |
1 |
|
|a Tosi, Giovanni.
|
| 758 |
|
|
|i has work:
|a Nanomedicine and Neurosciences (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYDbcrdcqw6xRPRD4FQFDq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Tosi, Giovanni.
|t Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects.
|d Sharjah : Bentham Science Publishers, ©2017
|z 9781681084947
|
| 830 |
|
0 |
|a Frontiers in Nanomedicine ;
|v v. 2.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4944120
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH37581000
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4944120
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1580981
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 14750079
|
| 994 |
|
|
|a 92
|b IZTAP
|
